Schisandra chinensis
SupplementThe discrepancy arises from the very limited clinical human study base relative to user experience (only 2 RCTs, n=111) [s7, s8], while community reports predominantly describe positive effects on stress and relaxation [c1, c2, c3]. The preclinically strong data [s3] do not justify a high medical rating without human confirmation.
Unlock full information
Dosages, side effects, studies and more — free after registration.
Register for freeRating Scales
TL;DR
Schisandra is a TCM adaptogen with a plausible mechanism — lignan-mediated antioxidation, NF-κB inhibition, hepatoprotective effects — but human evidence is limited to three small RCTs that consistently show effects on muscle strength and little else. The community appreciates its calming, mildly energising quality, though effects typically take 2–4 weeks to emerge and vary considerably between individuals. Critically for polypharmacy users: Schisandra inhibits CYP3A4 and can meaningfully raise plasma levels of co-administered drugs — this is not a theoretical edge case. It makes sense as an add-on to Rhodiola or Ashwagandha; as a standalone nootropic, the evidence base is too thin to justify strong claims.
Description
Adaptogenic medicinal herb from TCM with hepatoprotective, antioxidant, and potentially cognitive-supporting properties; evidence to date primarily from animal and in vitro studies for human applications [s1, s...
Schisandra chinensis (Turcz.) Baill., known in Traditional Chinese Medicine as "Wu Wei Zi" (berry of five flavors), is a woody climbing plant from the family Schisandraceae. Its berries have been used for centuries to strengthen the lungs, kidneys, and liver, as well as to combat fatigue and night sweats [s1, s4]. The primary bioactive compounds are lignans (e.g., schisandrin A, B, C; schisandrol A, B; gomisin), polysaccharides, and polyphenols [s3, s5]. These substances demonstrate hepatoprotective, antioxidant, anti-inflammatory, and anti-apoptotic effects in animal and in vitro studies [s3, s5, s6]. In the area of sports performance, one randomized placebo-controlled double-blind study with 71 athletes is available, suggesting improved physical endurance and reduced stress response [s7]. A further RCT examined effects on muscle strength and fatigue in women [s8]. For cognitive effects and hepatoprotection in humans, data are predominantly from animal experiments or in vitro studies, along with one preclinical meta-analysis [s3, s9]. Caution is warranted regarding drug interactions: Schisandra lignans inhibit CYP3A4 and P-glycoprotein, which may increase plasma levels of several drugs [s10, s11].
Legal Status (DE)
In Germany, Austria, and Switzerland, Schisandra chinensis is marketable as an over-the-counter food supplement (NEM) under the NemV and EU Food Supplements Directive 2002/46/EC [s14]. The EMA/HMPC has not yet published an official EU herbal monograph for Schisandra chinensis. A standalone EFSA safety assessment in a feed additive context is available (2024), but no novel food classification exists for human use [s15].
Mechanism of Action
The lignans of Schisandra chinensis exert their effects via multiple molecular mechanisms [s5, s6]: 1. **Antioxidation**: Schisandrin A, B, and C increase the activity of antioxidant enzymes (superoxide dismutase, glutathione peroxidase) and reduce malondialdehyde (MDA) as a marker of lipid peroxidation [s3, s5]. 2. **Hepatoprotection**: Inhibition of the NF-κB and MAPK signaling pathways reduces pro-inflammatory cytokines; anti-apoptotic effects protect hepatocytes from chemically induced cell death [s3, s6]. 3. **Adaptogenic effect / HPA axis**: Schisandra is considered an adaptogen and is proposed to modulate the stress response via the hypothalamic-pituitary-adrenocortical axis; however, direct RCT evidence in humans is largely lacking [s1, s7]. 4. **Neuroprotective effect**: Lignans (including schisandrin B) inhibit acetylcholinesterase, protect cortical neurons from oxidative stress, and can improve cognitive deficits in animal models [s9, s12]. 5. **CYP450 and P-gp inhibition**: Gomisins and schisandrins inhibit CYP3A4, CYP1A2, and P-glycoprotein in hepatic microsomes, thereby potentially altering the bioavailability of co-administered drugs [s10, s11].
Dosing
Adaptogen / Stressreduktion (Extrakt 5:1)
- Dose
- 500–1000 mg extract powder (equivalent to approx. 2.5–5 g berries)
- Frequency
- 1–2× täglich
- Route
- oral
- Duration
- 4–12 Wochen
- Timing
- Morning, or morning and midday; not in the evening due to possible stimulating effects
- With food
- empfohlen
Sportliche Leistung (placebokontrollierte Studie)
- Dose
- 600 mg Schisandra extract daily
- Frequency
- 1× täglich
- Route
- oral
- Duration
- 10–12 Wochen
- Timing
- Morning
- With food
- empfohlen
Muskelkraft/-ermüdung (RCT, Frauen)
- Dose
- 1000 mg Schisandra extract daily
- Frequency
- 1× täglich
- Route
- oral
- Duration
- 6 Wochen
- Timing
- Morning
- With food
- empfohlen
No officially established safety limit (UL) for Schisandra in German or EU regulation. Doses exceeding 2000 mg extract daily are not recommended due to the lack of long-term human studies [s13].
Schisandra extracts vary considerably in standardization (schisandrin content). Products without specification of lignan content are difficult to compare. Traditional recommendation: 1.5–6 g dried berries per day as tea or powder [s1, s4].
Side Effects
| Side Effect | Frequency | Severity |
|---|---|---|
| Sodbrennen, saures Aufstoßen, Magenbeschwerden Gastrointestinal complaints are the most frequently reported adverse effects in clinical and user reports [s13]. | gelegentlich | leicht |
| Hautreaktionen (Ausschlag, Juckreiz) Isolated reports of allergic skin reactions; causal relationship not clearly established [s13]. | selten | leicht |
| Unterdrückung des zentralen Nervensystems (hohe Dosen) Possible sedating or depressant CNS effects observed at high doses in animal models; not clearly established in humans [s13]. | selten | moderat |
| Uterusstimulation (Kontraktionen) Evidence of uterine-stimulating effects that could lead to miscarriage; pregnancy is therefore considered an absolute contraindication [s13, s16]. | theoretisch | schwer |
| Erhöhung von Arzneimittelspiegeln durch CYP3A4-Hemmung Schisandra lignans inhibit CYP3A4 and P-gp, which can lead to clinically relevant increases in drug plasma levels with co-medication [s10, s11]. | theoretisch | schwer |
Contraindications
Uterine stimulation by Schisandra constituents may induce contractions and increase the risk of miscarriage [s13, s16].
Insufficient safety data; transfer of lignans into breast milk cannot be excluded [s13, s16].
No safety data in children; traditional sources advise against use in children under 6 years of age [s4].
Schisandra lignans inhibit CYP3A4 and P-gp; plasma levels of immunosuppressants and other CYP3A4 substrates may rise to clinically relevant and potentially toxic concentrations [s10, s11].
Although hepatoprotective effects are discussed, clinical human evidence is lacking; medical consultation is mandatory in active liver disease [s3, s6].
Schisandra may aggravate heartburn and reflux; use should be avoided or closely monitored in patients with existing GERD [s13].
Interactions
Synergistic
The combination of Schisandra, Rhodiola, and Siberian ginseng (ADAPT-232) improved attention, speed, and accuracy within two hours compared to placebo in a controlled study of fatigued adults. This triple combination demonstrated synergistic adaptogenic effects for stress reduction and performance enhancement.
Both adaptogens modulate the HPA axis and may lower cortisol levels. In combination, they may synergistically reduce stress and fatigue, with Ashwagandha acting primarily on cortisol and Schisandra supporting focus and endurance.
Schisandra and Panax ginseng exhibit synergistic antioxidant and hepatoprotective effects. The combination of lignans and phenolic acids from both plants acts anti-inflammatory and promotes liver health. Mutual potentiation has been demonstrated in extraction studies.
Schisandra and Tulsi are frequently used together as an adaptogen combination to promote calm clarity and focus. Both act complementarily on stress axes and cognitive performance. The combination simultaneously supports concentration and anxiety reduction.
Caution
Schisandra may inhibit CYP3A4 and P-glycoprotein activity, thereby reducing the metabolism and active transport of berberine, which can lead to increased plasma concentrations and an enhanced pharmacological profile of berberine.
Schisandra inhibits CYP3A4 and P-glycoprotein, which may increase the bioavailability of liposomal curcumin; the liposomal formulation further enhances the already improved absorption, such that unpredictably high drug concentrations cannot be excluded.
Schisandra inhibits CYP3A4 and P-glycoprotein, which may affect the metabolism of alpha-lipoic acid. Although both exert antioxidant effects and are in principle complementary, the combination should be approached with caution when other substances are taken concomitantly. A direct adverse interaction is not documented, but elevated plasma levels are possible.
Studies
Tier A — High Evidence
Community Evidence
Top reported benefits
- Relaxation and mood elevation without pronounced sedation
- Improved stress tolerance with regular use
- Mild energy boost and mental clarity
- Adaptogenic long-term effect (perceived after 2–4 weeks)
- Positive effect on liver values (individual reports)
Top reported issues
- Mild stimulation or 'tweakiness' at higher doses (individual users)
- Gastrointestinal discomfort (heartburn, nausea)
- No noticeable effect in a subset of users
- Taste of dried berries described as unpleasant
Individual Reddit users report unwanted stimulation that overshadows other adaptogens (ashwagandha, rhodiola) [c3]. Effects are highly individual; acute effects occur less consistently than with L-theanine. German forums report little systematic experience; the data basis is limited [c4].
Scientific Sources
- Schisandra (Schisandra chinensis): Benefits, Safety, Uses – Herbal Reality
Herbal Reality Editorial Team (2023). Herbal Reality (herbalreality.com)BLink - A Comprehensive Review of the Main Lignan Components of Schisandra chinensis and Schisandra sphenanthera and the Lignan-Induced Drug-Drug Interactions Based on the Inhibition of Cytochrome P450 and P-Glycoprotein Activities
PMC Authors, et al. (2022). Frontiers in PharmacologyBDOI - Effects of schisandra lignans on the absorption of protopanaxadiol-type ginsenosides mediated by P-glycoprotein and protopanaxatriol-type ginsenosides mediated by CYP3A4
Authors listed on PubMed, et al. (2023). PubMed / primary journal not fully identifiedCPMID:37597677 - The study of therapeutic efficacy and mechanisms of Schisandra chinensis and Evodia rutaecarpa combined treatment in a rat model of Alzheimer's disease
PMC Authors, et al. (2023). PMC / PubMed CentralCLink - Schisandra: Dosierung, Nebenwirkungen und Wechselwirkungen
Drugs.com / WebMD / RxList Editorial (2024). drugs.com / webmd.com / rxlist.comBLink - Directive 2002/46/EC of the European Parliament and of the Council on the approximation of the laws of the Member States relating to food supplements
European Parliament, Council of the European Union (2002). Official Journal of the European CommunitiesALink - Safety and efficacy of a feed additive consisting of a tincture derived from the dried fruit of Schisandra chinensis (omicha tincture) for poultry, horses, dogs and cats
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) (2024). EFSA JournalADOI - Schisandra Nebenwirkungen, Kontraindikationen Schwangerschaft – Medicineh / Gigasnutrition / Lymeherbs
Medicineh Editorial, Gigasnutrition Editorial, Lymeherbs Editorial (2024). medicineh.com / gigasnutrition.com / lymeherbs.deCLink - Effect of Schisandra chinensis Baillon extracts and regular low-intensity exercise on muscle strength and mass in older adults: a randomized, double-blind, placebo-controlled trial
["Cho YH","Lee SY","Lee CH","Park JH","So YS"] (2021). The American Journal of Clinical NutritionCPMID:33710261DOI - Inhibitory Effects of Schisandra Lignans on Cytochrome P450s and Uridine 5′-Diphospho-Glucuronosyl Transferases in Human Liver Microsomes
Unbekannt (2021). PlantsCDOI - Schisandra – Memorial Sloan Kettering Cancer Center Herb Information
MSKCC Integrative Medicine Service (2024). Memorial Sloan Kettering Cancer CenterBLink - Efficacy of Schisandra chinensis in liver injury: a systematic review and preclinical meta-analysis
Authors not fully listed in search results, et al. (2025). Frontiers in PharmacologyAPMID:40832608DOI - Schisandra Wu Wei Zi: A TCM Herb for Nourishing Lungs, Tonifying Kidneys, and Protecting the Liver
HJ Medical Group Editorial (2023). HJ Medical Group (hjmedicalgroup.com)CLink - A comprehensive review of Schisandra chinensis lignans
PMC Authors, et al. (2025). PMC / PubMed CentralBLink - Schisandra chinensis in Liver Disease: Exploring the Mechanisms and Therapeutic Promise of an Ancient Chinese Botanical
Scientific Archives Editorial, et al. (2023). Scientific ArchivesBLink - Schisandra: The Ancient Adaptogen Athletes Are Rediscovering (double-blind placebo-controlled trial, n=71 athletes)
JS Performance Lab Editorial (citing primary study) (2023). JS Performance Lab / primary source not fully identifiedALink - Effect of Schisandra Chinensis Extract Supplementation on Quadriceps Muscle Strength and Fatigue in Adult Women: A Randomized, Double-Blind, Placebo-Controlled Trial
Authors listed on ResearchGate, et al. (2020). ResearchGate / primary journal not fully identified in search resultsALink - An overview of neuroprotective and cognitive enhancement properties of lignans from Schisandra chinensis
Authors listed on PubMed, et al. (2017). Biomedicine & PharmacotherapyBPMID:29136774DOI
Community Sources
Storage
Unopened
Store in a dry, cool (15–25 °C), light-protected location.
Opened
Keep container tightly closed; avoid moisture; consume within 12 months of opening.
Notes
Extracts and capsules should not be stored in humid environments (e.g., bathrooms). Dried berries and powders are particularly hygroscopic.